메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Coreline Soft Unveils AVIEW 2.0 at RSNA 2025: Next-Generation AI Pla…

CHICAGO and SEOUL, South Korea, Nov. 7, 2025 -- Coreline Soft will introduce its groundbreaking chest AI platform AVIEW 2.0 at RSNA 2025 (November 30–December 4, Chicago), demonstrating how unified AI automation is fundamentally transforming radiology workflows and elevating diagnostic precision across pulmonary, cardiac, and airway pathologies. AVIEW 2.0 represents a paradigm shift from task-specific tools to an integrated diagnostic ecosystem. The platform seamlessly combines lung-cancer screening (LCS), coronary-artery calcium scoring (CAC), and COPD quantifica
- 김갑성 기자
- 2025-11-07 21:00
'Coffee Diplomacy' at APEC: Korea-U.S. Startup Imunika Goes Vir…

Japan's newly appointed Foreign Minister Toshimitsu Motegi sparked an unexpected viral moment at APEC 2025 after stopping by Imunika — the official coffee sponsor of APEC 2025 Korea, a Korea–U.S. startup redefining "Wellness Specialty Coffee." SEOUL, South Korea and WASHINGTON, Nov. 7, 2025 -- A quiet exchange at the APEC 2025 Korea Summit became one of the event's most unexpected stories. Toshimitsu Motegi, Japan's newly appointed Foreign Minister — soon to help steer Japan–U.S. tariff negotiations — was filmed sampling Imunika, a small bio-fermented coffee startup that unex
- 김갑성 기자
- 2025-11-07 21:00
Pigeon Showcases Parenting Innovations Under "The Nes…

SHANGHAI, Nov. 7, 2025 -- During the 8th China International Import Expo (CIIE) at the National Exhibition and Convention Center, Pigeon unveiled its latest advances in feeding and baby care science under the theme "The Nest". 23 Years in China: Pigeon Expands from Local Innovation to Global Leadership Within the CIIE Consumer Goods exhibition area (Hall 6.1), Pigeon's baby feeding bottles have become a signature highlight. As the trusted global leader in high-quality, precision-engineered baby and maternity care products, Pigeon celebrates 23 years in C
- 김갑성 기자
- 2025-11-07 20:20
Alebund Presents Phase 3 Trial Results of AP301 at the Americ…

[ 메디채널 김갑성 기자 ] Clinically and statistically significant superiority of AP301 maintenance dose versus ineffective low dose in reducing serum phosphate levels was established and AP301's efficacy is sustained throughout the 52 weeks of treatment. The non-inferiority of AP301 to sevelamer carbonate in reducing serum phosphate levels was demonstrated. Overall, AP301 was safe and well-tolerated. The most common AEs were discolored feces and diarrhea. Diarrhea generally occurred early and resolved without treatment changes. No evidence of iron accumulation was observed with cumulative AP301
- 김갑성 기자
- 2025-11-07 20:00
Smartee Celebrates the Opening of its 4.0 Digital Orthodontic T…

JIAXING, China, Nov. 7, 2025 -- Smartee Denti-Technology has unveiled the Smartee Digital Orthodontic Technology Exhibition Hall, a 1,200-square-meter space dedicated to showcasing the company's innovations in clear aligner therapy and digital orthodontics. The event gathered a distinguished group of domestic orthodontic professionals, including Prof. Gang Shen and his orthodontic team, Ms. Paula Fabbie, Certified Orofacial Myologist and Examiner from IAOM (International Association of Orofacial Myology), Prof. Zhen Shi, Prof. Xue Feng, and Dr. Lei Shu, along with 21 orthodontists from
- 김갑성 기자
- 2025-11-07 18:05
Cranial Technologies Debuts NMPA-Cleared Infant Head Res…

SHANGHAI, Nov. 7, 2025 -- Cranial Technologies, a leading US medical device company specializing in the treatment of infant head shape conditions, officially introduced its flagship DOC Band® treatment in the Chinese market at the China International Import Expo (CIIE), taking place from November 5 to 10, 2025, in Shanghai. Cranial Technologies has treated over 400,000 infants across the United States and Europe. Its participation in CIIE marks a major milestone in the company's global expansion and its first entry into the Chinese market. "We are truly honored to parti
- 김갑성 기자
- 2025-11-07 15:58
Harbour BioMed and Evinova China Announce Strategic AI Co…

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 7, 2025 -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Evinova, a global health-tech company accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, announced a strategic collaboration in artificial intelligence (AI). Under the terms of the collaboration, Harbour BioMed and Ev
- 김갑성 기자
- 2025-11-07 14:00
Fosun International Honored with Gold Award and Best Susta…

HONG KONG, Nov. 7, 2025 -- On the evening of 6 November 2025, The Asset, a renowned Asian financial magazine, hosted "The Asset Corporate Sustainability Leadership Awards 2025" ceremony in Singapore. Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was awarded "The Asset Corporate Sustainability Leadership Awards 2025 – Gold Award" and the "Best Sustainability Team". Coinciding with The Asset's 25th anniversary, the highly regarded "The Asset ESG Corporate Awards" was renamed "
- 김갑성 기자
- 2025-11-07 09:00
Volpara Now Operates Under Lunit Brand, Advancing a Unifie…

The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 7, 2025 -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and therapeutics, today announced that Volpara Health Technologies will now operate under the Lunit brand, introducing a unified global identity that merges their complementary strengths in breast health and AI innovation. This milestone builds on Lunit's 2024 acquisition of Volpara, an important step tha
- 김갑성 기자
- 2025-11-07 08:14
ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes Inter…

SUZHOU, China, Nov. 7, 2025 -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced that the Company will present one of its autoimmune and inflammation pipeline assets, CS2015 (OX40L/TSLP bispecific antibody), in the format of an ePoster plus an on-site oral presentation at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI). ACAAI is one of the most influe
- 김갑성 기자
- 2025-11-07 08:10

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-12-11_THU

2025-12-10_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 11일 04시 00분